MDNC (Medinotec) Change In Receivables: $1.68 Mil (TTM As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDNC Medinotec Inc MDNC
24 GF Score
Price $5.00
! 1 Warning Sign
View Full Analysis

What is Medinotec Change In Receivables?

Medinotec MDNC 24 Change In Receivables is $1.68 Mil as of May. 2026. GuruFocus rates MDNC with a GF Score™ of 24/100. The stock has 1 warning sign investors should review.

Medinotec's change in receivables for the quarter that ended in May. 2026 was $-0.17 Mil. It means Medinotec's Accounts Receivable increased by $0.17 Mil from Feb. 2026 to May. 2026 .

Medinotec's change in receivables for the fiscal year that ended in Feb. 2026 was $0.26 Mil. It means Medinotec's Accounts Receivable declined by $0.26 Mil from Feb. 2025 to Feb. 2026 .

Medinotec's Accounts Receivable for the quarter that ended in May. 2026 was $2.51 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Medinotec's Days Sales Outstanding for the three months ended in May. 2026 was 86.53.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Medinotec's liquidation value for the three months ended in May. 2026 was $3.98 Mil.

Medinotec  (OTCPK:MDNC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Medinotec's Days Sales Outstanding for the quarter that ended in May. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=2.514/2.651*91
=86.53

2. In Ben Graham's calculation of liquidation value, Medinotec's accounts receivable are only considered to be worth 75% of book value:

Medinotec's liquidation value for the quarter that ended in May. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2.518-1.133+0.75 * 2.514+0.5 * 1.425
=3.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinotec Change In Receivables Related Terms

Medinotec Change In Receivables Historical Data

* Premium members only.

The historical data trend for Medinotec's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinotec Change In Receivables Chart

Medinotec Annual Data
Trend Feb22 Feb23 Feb24 Feb25 Feb26
Change In Receivables
0.00 -0.02 -0.63 -2.04 0.26

Medinotec Quarterly Data
Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.59 1.32 0.17 0.37 -0.17
MDNC
24GF Score
Medinotec Inc MDNC
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medinotec Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $1.68 Mil mean?
Medinotec (MDNC) has a Change In Receivables of $1.68 Mil as of May. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Medinotec and its competitors.
Is Medinotec's Change In Receivables too high?
Medinotec's current Change In Receivables is $1.68 Mil. Overall, Medinotec has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medinotec's Change In Receivables compare to NVNO and APYX?
Medinotec's Change In Receivables of $1.68 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Medinotec and its competitors. Medinotec's current Change In Receivables is $1.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinotec stock overvalued right now?
Medinotec (MDNC) has a current Change In Receivables of $1.68 Mil. The current Change In Receivables is $1.68 Mil. Medinotec's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Medinotec (MDNC), the current Change In Receivables is $1.68 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medinotec Business Description

Address Stand 299 Avant Garde Avenue, 10 New Market Street, Northlands Deco Park, North Riding, Johannesburg, GT, ZAF, 2169
Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.
24GF Score

Get the complete analysis for MDNC

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.00
Price